Antidote Therapeutics' Debt - II Round

Antidote Therapeutics raised a round of funding on September 05, 2017.

Antidote Therapeutics is assessing the protein properties of a novel nicotine degrading enzyme and its suitability for use as a smoking cessation treatment.…

Articles about Antidote Therapeutics' Debt - II Round: